ProPhase Labs, Inc.
PRPH
$0.10
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -11.21% | -29.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.21% | -29.19% | |||
| Cost of Revenue | -46.62% | 96.10% | |||
| Gross Profit | 300.81% | -116.76% | |||
| SG&A Expenses | 28.87% | 0.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.28% | 9.84% | |||
| Operating Income | -20.19% | -22.34% | |||
| Income Before Tax | -14.64% | -89.44% | |||
| Income Tax Expenses | -296.18% | -120.15% | |||
| Earnings from Continuing Operations | -8.17% | -52.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.17% | -52.93% | |||
| EBIT | -20.19% | -22.34% | |||
| EBITDA | -27.83% | -46.40% | |||
| EPS Basic | 79.68% | -52.93% | |||
| Normalized Basic EPS | 75.88% | -179.39% | |||
| EPS Diluted | 79.68% | -49.66% | |||
| Normalized Diluted EPS | 75.88% | -179.39% | |||
| Average Basic Shares Outstanding | 432.42% | 0.00% | |||
| Average Diluted Shares Outstanding | 432.42% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||